Latest News

The summit concluded with stakeholders committing to strengthen surveillance systems, build diagnostic capacity, and expand access to treatment throughout the continent.

The company plans to execute this investment through two primary channels: expanding existing facilities and forging partnerships with local manufacturers.

Through strategic partnerships similar to the Pharmalink agreement, the medication has already reached patients in China, Hong Kong, Japan, and various Latin American markets.

The Crimean-Congo haemorrhagic fever outbreak in Omaheke region was declared on 28 November 2025, following laboratory confirmation of a case on 21 November.

Chile detected its final locally acquired leprosy case in 1993, meaning the country has maintained zero local transmission for more than three decades.

Philips’ cloud-enabled offering supports secure remote access to images, simplifies data management at scale, and facilitates enterprise integration and AI-enabled applications across health systems.

CHAMPS has conducted minimally invasive post-mortem examinations on children who died within the facility to determine exact causes of death.

The NMPA based its approval decision on Phase III clinical trial data published in The Lancet Diabetes & Endocrinology in June 2025.

The facilities house 27 specialized production suites capable of manufacturing over 2 billion tablets and capsules annually, providing substantial capacity for both clinical and commercial-scale operations.

CSL plans to incorporate its Horizon 2 production process into the expanded facility, which the company describes as a cornerstone of its global manufacturing growth strategy.